Timothy L. Ratliff

19.7k total citations · 3 hit papers
274 papers, 15.1k citations indexed

About

Timothy L. Ratliff is a scholar working on Surgery, Immunology and Molecular Biology. According to data from OpenAlex, Timothy L. Ratliff has authored 274 papers receiving a total of 15.1k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Surgery, 85 papers in Immunology and 81 papers in Molecular Biology. Recurrent topics in Timothy L. Ratliff's work include Bladder and Urothelial Cancer Treatments (72 papers), Immunotherapy and Immune Responses (39 papers) and Urinary and Genital Oncology Studies (33 papers). Timothy L. Ratliff is often cited by papers focused on Bladder and Urothelial Cancer Treatments (72 papers), Immunotherapy and Immune Responses (39 papers) and Urinary and Genital Oncology Studies (33 papers). Timothy L. Ratliff collaborates with scholars based in United States, Germany and United Kingdom. Timothy L. Ratliff's co-authors include William J. Catàlona, Deborah S. Smith, Gerald L. Andriole, Bennett D. Elzey, Jerry J.J. Yuan, M’Liss A. Hudson, D.E. Coplen, John A. Petros, Peter A. Humphrey and Louis R. Kavoussi and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Timothy L. Ratliff

266 papers receiving 14.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

1991 1.8k citations William J. Catàlona, Timothy L. Ratliff et al. profile →
Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men

1994 1.1k citations William J. Catàlona, Timothy L. Ratliff et al. profile →
Cholesteryl Ester Accumulation Induced by PTEN Loss and PI3K/AKT Activation Underlies Human Prostate Cancer Aggressiveness

2014 688 citations Shuhua Yue, Junjie Li et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Timothy L. Ratliff United States	66	5.1k	4.4k	4.1k	2.9k	2.5k	274	15.1k
William R. Fair United States	75	7.2k 1.4×	7.3k 1.7×	4.1k 1.0×	828 0.3×	3.1k 1.2×	315	17.9k
Yves Fradet Canada	65	5.2k 1.0×	8.7k 2.0×	3.4k 0.8×	1.5k 0.5×	4.8k 1.9×	376	16.1k
Michael M. Lieber United States	72	7.9k 1.6×	3.5k 0.8×	4.4k 1.1×	793 0.3×	2.8k 1.1×	329	18.7k
Ulf‐Håkan Stenman Finland	70	4.7k 0.9×	2.9k 0.7×	5.5k 1.4×	1.9k 0.6×	4.1k 1.6×	608	20.1k
Colin P. Dinney United States	79	4.6k 0.9×	12.9k 2.9×	7.7k 1.9×	1.4k 0.5×	5.8k 2.3×	492	21.8k
Steven S. Shen United States	60	3.3k 0.6×	2.2k 0.5×	5.5k 1.4×	1.9k 0.7×	1.9k 0.8×	241	11.9k
Georg Bartsch Austria	65	4.7k 0.9×	3.0k 0.7×	2.9k 0.7×	1.4k 0.5×	1.6k 0.7×	299	11.9k
Thomas Horn Denmark	52	1.7k 0.3×	2.4k 0.6×	1.5k 0.4×	1.2k 0.4×	1.4k 0.6×	362	9.3k
Tania Roskams Belgium	83	3.2k 0.6×	8.3k 1.9×	6.6k 1.6×	1.7k 0.6×	4.7k 1.9×	428	25.9k
Paul E. Swanson United States	72	3.8k 0.7×	3.0k 0.7×	5.6k 1.4×	5.9k 2.0×	5.5k 2.2×	296	21.0k

Countries citing papers authored by Timothy L. Ratliff

Since Specialization

Citations

This map shows the geographic impact of Timothy L. Ratliff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy L. Ratliff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy L. Ratliff more than expected).

Fields of papers citing papers by Timothy L. Ratliff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy L. Ratliff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy L. Ratliff. The network helps show where Timothy L. Ratliff may publish in the future.

Co-authorship network of co-authors of Timothy L. Ratliff

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy L. Ratliff. A scholar is included among the top collaborators of Timothy L. Ratliff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy L. Ratliff. Timothy L. Ratliff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Meng, Fanfei, Jiaqi Zhao, Zhongyue Yuan, et al.. (2025). Timely administration of drug combination improves chemoimmunotherapy of an immune-cold tumor. Journal of Controlled Release. 381. 113579–113579. 3 indexed citations

Meng, Fanfei, et al.. (2024). Systemic Delivery of Paclitaxel by Find-Me Nanoparticles Activates Antitumor Immunity and Eliminates Tumors. ACS Nano. 18(4). 3681–3698. 23 indexed citations

Anczuków, Olga, Jeffrey H. Chuang, Lisa M. Coussens, et al.. (2023). Challenges and opportunities for modeling aging and cancer. Cancer Cell. 41(4). 641–645. 15 indexed citations

Akhand, Saeed Salehin, Ammara Abdullah, Hang Lin, et al.. (2020). Pharmacologic Inhibition of FGFR Modulates the Metastatic Immune Microenvironment and Promotes Response to Immune Checkpoint Blockade. Cancer Immunology Research. 8(12). 1542–1553. 26 indexed citations

Fang, Shuyi, Sheng Liu, Xufeng Chen, et al.. (2020). Protein Arginine Methyltransferase 5 Promotes pICln-Dependent Androgen Receptor Transcription in Castration-Resistant Prostate Cancer. Cancer Research. 80(22). 4904–4917. 28 indexed citations

Vickman, Renee E., Jiang Yang, Nadia A. Lanman, et al.. (2019). Cholesterol Sulfotransferase SULT2B1b Modulates Sensitivity to Death Receptor Ligand TNFα in Castration-Resistant Prostate Cancer. Molecular Cancer Research. 17(6). 1253–1263. 8 indexed citations

Lee, Hyeon Jeong, Jie Li, Renee E. Vickman, et al.. (2018). Cholesterol Esterification Inhibition Suppresses Prostate Cancer Metastasis by Impairing the Wnt/β-catenin Pathway. Molecular Cancer Research. 16(6). 974–985. 72 indexed citations

Orillion, Ashley, Nur P. Damayanti, Li Shen, et al.. (2018). Dietary Protein Restriction Reprograms Tumor-Associated Macrophages and Enhances Immunotherapy. Clinical Cancer Research. 24(24). 6383–6395. 85 indexed citations

Yue, Zongliang, et al.. (2018). “Super Gene Set” Causal Relationship Discovery from Functional Genomics Data. IEEE/ACM Transactions on Computational Biology and Bioinformatics. 15(6). 1991–1998. 2 indexed citations

10.

Li, Jie, Ruixin Wang, Yifan Kong, et al.. (2017). Targeting Plk1 to Enhance Efficacy of Olaparib in Castration-Resistant Prostate Cancer. Molecular Cancer Therapeutics. 16(3). 469–479. 43 indexed citations

11.

Yue, Feng, Pengpeng Bi, Chao Wang, et al.. (2017). Pten is necessary for the quiescence and maintenance of adult muscle stem cells. Nature Communications. 8(1). 14328–14328. 90 indexed citations

12.

Vickman, Renee E., Scott A. Crist, Lívia S. Eberlin, et al.. (2016). Cholesterol Sulfonation Enzyme, SULT2B1b, Modulates AR and Cell Growth Properties in Prostate Cancer. Molecular Cancer Research. 14(9). 776–786. 23 indexed citations

13.

Bahler, Clinton D., et al.. (2016). Novel Use of Folate-Targeted Intraoperative Fluorescence, OTL38, in Robot-Assisted Laparoscopic Partial Nephrectomy: Report of the First Three Cases. Journal of Endourology Case Reports. 2(1). 189–197. 36 indexed citations

14.

Yue, Shuhua, Junjie Li, Seung Young Lee, et al.. (2014). Cholesteryl Ester Accumulation Induced by PTEN Loss and PI3K/AKT Activation Underlies Human Prostate Cancer Aggressiveness. PMC. 4 indexed citations

15.

Song, Bing, X. Shawn Liu, Shihuan Kuang, et al.. (2012). Plk1 Phosphorylation of Orc2 and Hbo1 Contributes to Gemcitabine Resistance in Pancreatic Cancer. Molecular Cancer Therapeutics. 12(1). 58–68. 62 indexed citations

16.

Lubaroff, David M., et al.. (2009). Phase I Clinical Trial of an Adenovirus/Prostate-Specific Antigen Vaccine for Prostate Cancer: Safety and Immunologic Results. Clinical Cancer Research. 15(23). 7375–7380. 66 indexed citations

17.

Elzey, Bennett D., et al.. (2007). The fibronectin attachment protein of bacillus Calmette-Guerin (BCG) mediates antitumor activity. Cancer Immunology Immunotherapy. 57(4). 573–579. 25 indexed citations

18.

Siemens, D. Robert, et al.. (2006). Induction of protective immunity to RM‐1 prostate cancer cells with ALVAC‐IL‐2/IL‐12/TNF‐α combination therapy. International Journal of Cancer. 119(11). 2632–2641. 14 indexed citations

19.

Aslanzadeh, Jaber, et al.. (1989). Characterization of Soluble Fibronectin Binding to Bacille Calmette-Guerin. Microbiology. 135(10). 2735–2741. 25 indexed citations

20.

McCool, Robert E., William J. Catàlona, Marlyn P. Langford, & Timothy L. Ratliff. (1981). Induction of human gamma interferon by protein A from Staphylococcus aureus. Journal of Interferon Research. 1(4). 473–481. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact